Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Solving the Mysteries of Regeneration

Published: Thursday, August 22, 2013
Last Updated: Thursday, August 22, 2013
Bookmark and Share
Biologist Peter Reddien seeks to understand planarians’ famous ability to grow new body parts.

Few animals can rival the amazing regeneration abilities of the flatworms known as planarians: When the worms’ tails or heads are cut off, they grow new ones, and even a tiny piece of planarian tissue can regrow an entire animal.

Scientists first observed these phenomena more than a century ago, but until the past few years, they knew very little about how planarians achieve these incredible feats. MIT associate professor of biology Peter Reddien has made it his mission to discover the genetic and molecular basis of planarian regeneration, which he describes as one of the great mysteries of biology.

“Cellular and molecular insight into regeneration has come far in the past decade, but we’ve still got a long way to go to understand how an animal regrows a missing body part,” says Reddien, who is a core member of MIT’s Whitehead Institute. “That is the obsessive focus of my lab — to try to understand how regeneration happens, with the conviction that generation of fundamental knowledge about regeneration works will be important for understanding biology broadly and also for generating ideas for therapeutic applications.”

In recent years, Reddien’s lab has identified dozens of genes involved in planarian regeneration. Many of these are related to human genes, and some are active in response to human injuries. “It’s my hope that our continued work will enhance our understanding of what makes some animals great at regeneration and others not as good,” he says.

‘A golden era’


Growing up in Dallas, Reddien was drawn not to planarians but to planets. He closely followed the exploits of NASA, especially the travels of the Voyager spacecraft, with Voyager 2 reaching Neptune and heading out of the solar system by the time Reddien was 15 years old. “From a young age I thought I would be a physicist who would work for NASA or the Jet Propulsion Laboratory,” he says.

He entered the University of Texas as a physics major, but shifted gears after taking a required biology course.

“I realized that we were in a golden era for biological research, that this was going to be a period in history unlike any other for biological research … a period of great discoveries about how the fundamental attributes of life work,” Reddien recalls. “I found that exhilarating, and I got very excited about that as a future potential path for me.”

After graduating from college, Reddien came to MIT as a graduate student in molecular biology, working with Robert Horvitz, now the David H. Koch Professor of Biology. Among other projects, Horvitz’s lab was studying the molecular mechanisms of programmed cell death, a process critical to embryonic development and in defending against cancer.

Reddien finished his PhD in 2002 — the year Horvitz won the Nobel Prize in physiology or medicine for his work in programmed cell death — and went to the University of Utah to do postdoctoral research on regeneration. Reddien describes his decision at the time to launch into study of the molecular basis of regeneration in planarians as “a bit of a gamble.”

“There was a lot of potential, but it was off the radar and in its early stages as a molecular genetic field,” he says. “At that time, the tools for studying gene function in this organism were just in their infancy. There were no published roles for any gene at the time based on disrupting genes and studying what goes wrong in regeneration.”

At Utah, Reddien worked in the lab of Alejandro Sánchez Alvarado, who had recently shown that a new technique known as RNA interference, which allows genes to be selectively turned off, could work in planarians. Until that point, genetic studies of planarian regeneration had not been possible. Reddien was confident that new tools such as RNA interference could get planarians to reveal their regeneration secrets.

“No one had done it, and it was not an established system for taking that type of approach, so I did feel like I was taking a bit of a risk,” Reddien says. “It worked out better than I could have hoped, but I knew that the road was going to be full of challenges because there weren’t established paths to follow to study regeneration defects in these animals.”

A fundamental approach

Since joining the MIT faculty in 2005, Reddien has discovered dozens of genes that play key roles in regeneration, whether initiating the process or helping to determine which body part needs to be replaced. One gene that his lab investigated, known as notum, interacts with a cell-communication system called the Wnt signaling pathway to control whether an animal regrows a head or a tail.

Reddien also found that adult planarians maintain a population of pluripotent stem cells, known as clonogenic neoblasts, that can grow into any type of tissue. These cells are key to tissue regeneration, and his lab has identified genes that give these cells their regenerative potential.

“This is the kind of science you dream of when you’re a kid,” Reddien says. “We’re cutting off animals’ heads and figuring out how they regrow new ones at a molecular level. It’s up to us to develop the methods we need to solve these problems because it’s such a new field. It’s just been a real adventure and that’s something I’m greatly drawn to in science.”

Many of the genes that Reddien has discovered in planarians have counterparts in the human genome, though the functions of many in humans have been little studied. Learning more about them could help advance the field of regenerative medicine.

“We are taking a fundamental science approach to the problem, with the idea that evolution has already selected for mechanisms that allow regenerative repair events that would be the dream of regenerative medicine. The hope is that understanding these mechanisms could lead to new ideas about how applications could be derived to enhance wound healing and repair in humans,” Reddien says.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Nanosensors Could Determine Tumours’ Ability to Remodel Tissue
Researchers design nanosensors that can profile tumours, focusing on protease levels.
Thursday, September 29, 2016
High-Capacity Nanoparticles
New type of nanoparticle can now have three or more drugs packaged within it, allowing for customised cancer therapy.
Thursday, September 15, 2016
Delivering Beneficial Bacteria
Method that transports microbes through the stomach to the intestine may benefit human health.
Thursday, September 15, 2016
Linking RNA Structure and Function
Biologists have deciphered a lncRNA structure and used the information to investigate its cellular protein interactions.
Friday, September 09, 2016
Hacking Microbes
Startup’s engineered yeast helps clients produce fragrances and flavors more efficiently.
Thursday, September 08, 2016
Guided Needles Hit the Mark
New sensor could help anesthesiologists place needles for epidurals and other medical procedures.
Thursday, September 08, 2016
Changing Ocean Chemistry Due To Human Activity
More anthropogenic carbon in the northeast Pacific means weaker shells for many marine species.
Wednesday, September 07, 2016
Targeting Neglected Diseases
New enzyme-mapping advancement could help drug development for combating diseases in the developing world.
Wednesday, August 17, 2016
Protecting Privacy in Genomic Databases
System helps ensure databases used in medical research will not leak patients’ personal information.
Wednesday, August 10, 2016
Biopharmaceuticals on Demand
Portable production system would use microbes for manufacturing small amounts of vaccines and therapeutics.
Monday, August 01, 2016
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Wednesday, July 27, 2016
New Device can Study Electric Field Cancer Therapy
Microfluidic device allows study of electric field cancer therapy through low-intensity fields, preventing malignant cells spreading.
Friday, July 08, 2016
Programmable RNA Vaccines
Tests in mice show the vaccines work against Ebola, influenza, and a common parasite.
Wednesday, July 06, 2016
Seeing RNA at the Nanoscale
MIT researchers have developed a new way to image proteins and RNA inside neurons of brain tissue.
Wednesday, July 06, 2016
Tough New Hydrogel Hybrid Doesn’t Dry Out
Water-based material could be used to make artificial skin, longer-lasting contact lenses.
Friday, July 01, 2016
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
How Baby’s Genes Influence Birth Weight And Later Life Disease
The large-scale study could help to target new ways of preventing and treating these diseases.
Genes Underlying Dogs’ Social Ability Revealed
The social ability of dogs is affected by genes that also seem to influence human behaviour, according to a new study from Linköping University in Sweden.
‘Cellbots’ Chase Down Cancer, Deliver Drugs Directly to Tumors
Programmable T cells shown to be versatile, precise, and powerful in lab studies.
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
C Dots Show Powerful Tumor Killing Effect
Nanoparticles known as Cornell dots, or C dots, have shown great promise as a therapeutic tool in the detection and treatment of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!